Skip to main content
. 2020 Jul 14;76(4):1104–1112. doi: 10.1161/HYPERTENSIONAHA.120.15528

Figure 2.

Figure 2.

The percentage survival of patients with cardiac biomarker levels under cutoffs, between cutoffs and upper limits of normal (ULNs), and above ULNs of high-sensitivity cardiac troponin I (hs-cTnI; A), CK (creatine phosphokinase)-MB; B), (NT-pro)BNP (N-terminal pro-B-type natriuretic peptide or brain natriuretic peptide); C), MYO (myoglobin; D), and CK (E). HR indicates hazard ratio.